ArticleScientific reports2026
Exploring provider attitudes towards digital therapeutics for diabetes and depression.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Digital therapeutics (DTxs) are AI-enabled FDA-regulated health apps prescribed to patients for a variety of conditions. DTxs use several methods including gamification, health education, and personalized insights to deliver targeted health behavior modification for users to self-manage a treatment or therapy, and or make necessary lifestyle changes. We investigate primary care provider attitudes (n = 224) towards adding DTxs to treatment plans for adult patients with diabetes or depression using experimental vignettes to examine differences in referral rates for a DTx versus in-person self-management program for patients with diabetes or depression of different ethnic and racial identities (Black, Latine, or White), ages (25 or 68), and sexes (male or female). In the findings of this pilot, we did not detect a difference in judgments of effectiveness of DTxs compared to in-person programs. When adjusting for all other variables, we found a statistically significant difference in belief that a digital therapeutic would be more effective than a self-management program for patients with diabetes compared to patients with depression (p < 0.05). In addition, providers overwhelmingly opted to let the patient decide the intervention, often emphasizing shared or patient-centered/driven care decision-making. Overall, these results suggest that, when informed that an in-person program and DTxs are equally effective, providers may consider them equally for their patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.